# Gilead Sciences, Inc. (GILD): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/gild for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Drug Manufacturers - General
- Exchange: NASDAQ · Trading currency: USD

Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations spanning the United States, Europe, and numerous international markets. Its core mission involves discovering, developing, and commercializing innovative medications to address critical health needs. The company's extensive product portfolio encompasses treatments for a variety of severe conditions. For HIV/AIDS, it supplies key therapies such as Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla. In response to the 2019 coronavirus pandemic, Gilead provides Veklury, an inject...

## Quote & Key Metrics

As of 2026-10-23:

| Metric | Value |
|---|---|
| Price | $156.04 USD |
| Market Cap | $193.48B |
| P/E (TTM) | — |
| EPS (TTM) | −$0.39 |
| 52-Week Range | $114.02 – $160.51 |
| Dividend Yield (TTM) | 2.08% |

## Dividend

| Metric | Value |
|---|---|
| Yield (TTM) | 2.08% |
| Annual Dividend (TTM) | $3.25 /share |
| Annual Dividend (Forward) | $3.28 /share |
| Frequency | Quarterly |
| Consecutive Growth Streak | 11 years |
| Growth CAGR 1Y / 3Y / 5Y / 10Y | 3.8% / 3.0% / 2.9% / 5.7% |
| Payout Ratio (EPS, TTM) | -120.6% |
| Payout Ratio (FCF, TTM) | — |
| Payout Ratio (EPS, forward dividend) | -122.8% |
| Payout Ratio (FCF, forward dividend) | — |

### Recent Payments

| Ex-Date | Amount | Pay Date |
|---|---|---|
| 2026-09-15 | $0.8200 | 2026-09-29 |
| 2026-06-15 | $0.8200 | 2026-06-29 |
| 2026-03-13 | $0.8200 | 2026-03-30 |
| 2025-12-15 | $0.7900 | 2025-12-30 |
| 2025-09-15 | $0.7900 | 2025-09-29 |
| 2025-06-13 | $0.7900 | 2025-06-27 |
| 2025-03-14 | $0.7900 | 2025-03-28 |
| 2024-12-13 | $0.7700 | 2024-12-30 |
| 2024-09-13 | $0.7700 | 2024-09-27 |
| 2024-06-14 | $0.7700 | 2024-06-27 |
| 2024-03-14 | $0.7700 | 2024-03-28 |
| 2023-12-14 | $0.7500 | 2023-12-28 |

Full history: https://www.dividenddata.com/stocks/gild/dividend

## Frequently Asked Questions

### What does Gilead Sciences, Inc. do?

Gilead Sciences, Inc. (GILD) operates in the Drug Manufacturers - General industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is GILD's market cap?

Gilead Sciences, Inc. (GILD) has a market capitalization of approximately $193.48 billion, as of October 23, 2026, based on the most recent share price and shares outstanding.

### Does GILD pay a dividend?

Yes, Gilead Sciences, Inc. (GILD) pays a dividend quarterly, with a trailing-twelve-month yield of 2.08%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

### Is GILD profitable?

Gilead Sciences, Inc. (GILD) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### How often does GILD pay dividends?

Gilead Sciences, Inc. pays dividends quarterly. The forward annual rate is $3.28 per share at the current declared cadence. Each ex-dividend date, record date, and payment date is listed in the dividend history table on this page.

### What is GILD's payout ratio?

Gilead Sciences, Inc.'s payout ratio is the percentage of earnings (and free cash flow) returned to shareholders as dividends. Current EPS and FCF coverage are shown in the payout cards above, with green / amber / red coloring indicating sustainability.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/gild
- Dividend history & safety: https://www.dividenddata.com/stocks/gild/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/gild/earnings
- Financial statements: https://www.dividenddata.com/stocks/gild/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/gild/valuation
- Peer comparison: https://www.dividenddata.com/stocks/gild/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.